Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions-Reference-Cited by-同舟云学术

Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions

Published:2017-03 Issue:3 Volume:19 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Wang Xiao Jun,Chan Alexandre

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-017-0578-5.pdf

Reference68 articles.

1. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011;52(4):e56–93.

2. Klastersky J, de Naurois J, Rolston K, et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2016;27(suppl 5):v111–8.

3. Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2013;31(6):794–810.

4. Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. European journal of cancer (Oxford, England: 1990). 2011;47(1):8–32.

5. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Myeloid Growth Factors. v2.2016. Available from https://www.nccn.org/professionals/physician_gls/pdf/myeloid_growth.pdf (2016) Accessed 21 Sept 2016.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: a systematic review and meta-analysis;Hematology;2023-01-31

2. Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy;Scientific Reports;2022-02-15

3. Effectiveness of a conservation energy model for febrile neutropenia in children with cancer;Pediatric Reports;2020-06-25

4. Current management of chemotherapy-induced neutropenia in adults: key points and new challenges;Cancer Biology and Medicine;2020

5. The calcium‐sensing receptor: A novel target for treatment and prophylaxis of neratinib‐induced diarrhea;Pharmacology Research & Perspectives;2019-09-13